[1]寄婧,王恒国,张丽蓉,等.心脏康复训练联合艾灸对乳腺癌化疗患者心功能和活动耐力的影响[J].西部中医药,2026,39(04):139-143.[doi:10.12174/j.issn.2096-9600.2026.04.30]
　JI Jing,WANG Hengguo,ZHANG Lirong,et al.Effect of Cardiac Rehabilitation Joined with Moxibustion on Cardiac Function and Activity Endurance in Patients with Breast Cancer Undergoing Chemotherapy[J].Western Journal of Traditional Chinese Medicine,2026,39(04):139-143.[doi:10.12174/j.issn.2096-9600.2026.04.30]
点击复制

心脏康复训练联合艾灸对乳腺癌化疗患者心功能和活动耐力的影响()

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
39
期数:
2026年04期
页码:
139-143
栏目:
特色医疗
出版日期:
2026-04-15

文章信息/Info

Title:
Effect of Cardiac Rehabilitation Joined with Moxibustion on Cardiac Function and Activity Endurance in Patients with Breast Cancer Undergoing Chemotherapy
作者:
寄婧1, 王恒国2, 张丽蓉1, 李宁1, 孙巧芬1, 陆静2, 蒋凯凯2
1.甘肃省中医院，甘肃 兰州 730050
2.甘肃中医药大学，甘肃 兰州 730000
Author(s):
JI Jing1, WANG Hengguo2, ZHANG Lirong1, LI Ning1, SUN Qiaofen1, LU Jing2, JIANG Kaikai2
1.Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China
2.Gansu University of Chinese Medicine, Lanzhou 730000, China
关键词:
乳腺癌; 心功能; 活动耐力; 心脏康复; 蒽环类药物
Keywords:
breast cancer; cardiac function; activity endurance; cardiac rehabilitation; anthracycline
分类号:
R271.9
DOI:
10.12174/j.issn.2096-9600.2026.04.30
文献标志码:
B
摘要:
目的观察早期心脏康复训练联合艾灸对接受蒽环类药物化疗的乳腺癌患者心功能及活动耐力的改善作用。 方法将32例乳腺癌术后拟行蒽环类药物化疗的患者，按1∶1比例随机分为对照组和试验组。两组均采用相同化疗方案，对照组予常规护理，试验组在对照组基础上予心脏康复训练。比较两组患者化疗前（T1）、第1次化疗结束后2周（T2）、第4次化疗结束后2周（T3）以及整个化疗周期结束后2个月（T4）、6个月（T5）的左心室射血分数（left ventricular ejection fraction，LVEF）、6分钟步行试验距离（the six minutes walking distance，6MWD）及视觉模拟量表（visual analogue scale，VAS）评分。 结果化疗前（T1）两组患者LVEF及6MWD比较，差异无统计学意义（P＞0.05）；化疗开始后两组患者LVEF均降低，6MWD均增加，T2、T3、T4各节点比较差异均无统计学意义（P＞0.05）；两组患者T5时段LVEF较T1明显降低（P＜0.05），6MWD较T1明显增加（P＜0.05）。化疗前（T1）两组患者VAS评分比较差异无统计学意义（P＞0.05）；化疗开始后两组患者VAS评分逐渐降低，与T1比较，两组患者T2、T3时VAS评分无明显改变（P＞0.05），T4、T5时明显降低（P＜0.01），且试验组下降幅度高于对照组（P＜0.01）。 结论心脏康复训练可减缓蒽环类药物化疗导致的心功能下降，提升活动耐力并减轻疲劳，从而改善乳腺癌患者的生存质量。
Abstract:
ObjectiveTo explore the improvement of early cardiac rehabilitation intervention and moxibus-tion on cardiac function and activity endurance in breast cancer patients undergoing anthracycline chemotherapy. MethodsAll 32 patients who qualifies for proposed anthracycline chemotherapy after the surgery of breast cancer were randomly divided into a control group and an experimental group at a ratio of 1:1. The two groups adopted the same chemotherapy, the control group received conventional care, while cardiac rehabilitation was given to the experimental group. To compare LVEF, 6MWD and VAS scores before chemotherapy (T1), two weeks after the first chemotherapy (T2), two weeks after the forth chemotherapy (T3), two months after the chemotherapy cycle (T4), and six months (T5) between the two groups. ResultsThe difference had no statistical meaning in LVEF and 6MWD between the two groups before chemotherapy (T1) (P>0.05); a decrease in LVEF and an increase in 6MWD were found since the beginning of chemotherapy, there was no significant difference in T2, T3 and T4 (P>0.05); LVEF were noticeably lower at T5 compared with T1 in the two groups (P<0.05), 6MWD rose evidently than T1 (P<0.05). The difference had no statistical meaning in VAS scores before chemotherapy (T1) (P>0.05); VAS scores gradually reduced in the two groups since the beginning of chemotherapy, VAS scores showed no obvious changes at T2 and T3 when compared with T1 (P>0.05), and a significant decrease in the scores was seen at T4 and T5 (P<0.01), and the decrease of the experimental group was higher than that of the control group (P<0.01). ConclusionCardiac rehabilitation intervention could slow down the decline in cardiac function caused by anthracycline chemotherapy, improve activity endurance and reduce fatigue, thereby enhancing the quality of life of breast cancer patients.

相似文献/References:

[1]孙国荣,景克荣,权亚喜.生脉注射液对慢性心衰患者心功能及其心率变异性的影响[J].西部中医药,2013,26(04):68.
　SUN Guorong,JING Kerong,QUAN Yaxi.The Influence of ShengMai Injection on Heart Function and Heart Rate Variability of Patients with Chronic Heart Failure[J].Western Journal of Traditional Chinese Medicine,2013,26(04):68.
[2]王斌,王艳杰,梁贵文,等.乳积方防治乳腺癌患者术后复发转移的临床研究*[J].西部中医药,2013,26(08):101.
　WANG Bin,WANG Yanjie,LIANG Guiwen,et al.Clinical Study on RuJiFang to Prevent Postoperative Recurrence and Metastasis of Breast Cancer[J].Western Journal of Traditional Chinese Medicine,2013,26(04):101.
[3]侯俊明,江静.疏肝解郁法联合化疗治疗乳腺癌临床疗效分析[J].西部中医药,2014,27(09):1.
[4]王丽,何丽娟,朱玉芹.循证护理对乳腺癌化疗患者自尊水平和应对方式的影响[J].西部中医药,2014,27(11):134.
[5]朱慧华.纽曼护理对乳腺癌手术患者心理健康和生活质量的影响[J].西部中医药,2014,27(12):105.
[6]张晓华,张晓岚△,梁玉荣,等.综合心理干预对乳腺癌化疗患者医学应对方式及生命质量的影响[J].西部中医药,2015,28(07):123.
[7]谷雨,华海清△.中医辨证分型与乳腺癌预后的相关性研究[J].西部中医药,2015,28(04):85.
[8]吉利,张艳.益气通脉饮对慢性心力衰竭大鼠心功能及血清TNF-α、IL-6、TGF-β1水平的影响[J].西部中医药,2015,28(05):25.
[9]刘琛,吴黎雅,赵红佳,等.人参养荣汤干预乳腺癌新辅助化疗所致气血两虚证的临床研究[J].西部中医药,2011,24(11):3.
[10]李树建.扶正祛积汤联合CEF化疗方案治疗晚期乳腺癌40例临床研究[J].西部中医药,2013,26(09):1.
　LI Shujian.Clinical Study on FuZheng QuJiTang Combined with CEF Chemotherapy in Treating 40 Patients Suffering from Advanced Mammary Cancer[J].Western Journal of Traditional Chinese Medicine,2013,26(04):1.

备注/Memo

备注/Memo:
甘肃省自然科学重点研发计划项目（21YF11FA006）。寄婧（1967—），女，主任医师。研究方向：中枢神经损伤、肿瘤等疾病所致运动、心肺功能障碍的综合康复评定与治疗。Email：2472770527@qq.com。
更新日期/Last Update: 2026-04-15